Mesenchymal Stem Cell-derived Exosome; An Interesting Nanocarrier to Improve Allergen-specific Intranasal Immunotherapy
In conclusion, the Exo-OVA improved the INIT efficacy compared to free OVA. Therefore, this formulation could be introduced as an effective approach for immunomodulatory purposes with a shorter treatment duration and reduced side effects.PMID:38477953 | DOI:10.18502/ijaai.v22i6.14645
Source: Cancer Control - Category: Cancer & Oncology Authors: Sajad Dehnavi Maryam Dadmanesh Negin Hosseini Rouzbahani Mahmood Karimi Ali Asadirad Mohammad Gholami Khodayar Ghorban Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Cancer | Cancer & Oncology | Immunotherapy | Iran Health | Middle East Health | Nanotechnology | Nasopharyngeal Cancer | Stem Cell Therapy | Stem Cells | Study